Portfolio Update

RNS Number : 2653U

Intl. Biotechnology Trust PLC

16 January 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 December 2016

Net Assets	£225m
Net Assets per share	599p
Share price	550p
Total value of unquoted investments	£26m
Total number of portfolio companies	77

Top Ten Holdings

Company Name	% NAV
Celgene	7.6
Biogen	6.7
Genmab	6.3
Alexion	5.9
Shire	5.8
Tesaro	4.6
Gilead	4.5
Regeneron	4.3
Amgen	4.2
Novo	3.4
	-----------
Total	53.3

Geographical Allocation	% NAV
US & Canada	78
Europe & UK	22
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	89
Unquoted	11
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	58
Mid Cap =USD1-10BN	21
Small Cap <USD1BN	21
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	38
Orphan	12
CNS	11
Inflammation	8
Ophthalmology	5
Medtech	3
Other	23
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

16 JANUARY 2017

 

END

 

 

PFUBBGDBCXBBGRL